Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by Securian Asset Management Inc.

Securian Asset Management Inc. reduced its position in Mettler-Toledo International Inc. (NYSE:MTD) by 8.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,133 shares of the medical instruments supplier’s stock after selling 105 shares during the quarter. Securian Asset Management Inc.’s holdings in Mettler-Toledo International were worth $1,386,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. State Street Corp grew its position in Mettler-Toledo International by 1.0% in the 3rd quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock valued at $1,431,693,000 after acquiring an additional 9,009 shares in the last quarter. Geode Capital Management LLC grew its position in Mettler-Toledo International by 0.8% in the 3rd quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after acquiring an additional 4,166 shares in the last quarter. Principal Financial Group Inc. grew its position in Mettler-Toledo International by 13.9% in the 4th quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock valued at $335,977,000 after acquiring an additional 33,456 shares in the last quarter. Barclays PLC boosted its stake in shares of Mettler-Toledo International by 8.3% in the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after buying an additional 19,609 shares during the period. Finally, JPMorgan Chase & Co. boosted its stake in shares of Mettler-Toledo International by 14.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after buying an additional 28,478 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

MTD has been the subject of several recent research reports. Evercore ISI lifted their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research note on Monday, February 10th. Citigroup decreased their price objective on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th. Wolfe Research initiated coverage on Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating for the company. Wells Fargo & Company lifted their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday, February 10th. Finally, Robert W. Baird lifted their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Mettler-Toledo International has an average rating of “Hold” and a consensus price target of $1,380.50.

Mettler-Toledo International Stock Up 2.4 %

MTD stock opened at $1,231.32 on Friday. The business has a 50 day moving average price of $1,295.03 and a 200 day moving average price of $1,318.19. The stock has a market cap of $25.75 billion, a price-to-earnings ratio of 30.38, a PEG ratio of 3.30 and a beta of 1.15. Mettler-Toledo International Inc. has a fifty-two week low of $1,142.91 and a fifty-two week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, sell-side analysts anticipate that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Christian Magloth sold 790 shares of the business’s stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the sale, the insider now owns 734 shares in the company, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Gerry Keller sold 600 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the transaction, the insider now directly owns 6 shares in the company, valued at approximately $8,108.04. The trade was a 99.01 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.